Conditions:  Anatomic Stage IV Breast Cancer AJCC v8;  Clinical Stage IV Cutaneous Melanoma AJCC v8;  Hematopoietic and Lymphoid Cell Neoplasm;  Hormone Receptor Positive Breast Adenocarcinoma;  Metastatic Lung Non-Small Cell Carcinoma;  Metastatic Malignant Neoplasm in the Brain;  Metastatic Malignant Solid Neoplasm;  Metastatic Melanoma;  Metastatic Triple-Negative Breast Carcinoma;  Pathologic Stage IV Cutaneous Melanoma AJCC v8;  Prognostic Stage IV Breast Cancer AJCC v8;  Stage IV Lung Cancer AJCC v8;  Stage IVA Lung Cancer AJCC v8;  Stage IVB Lung Cancer AJCC v8
Interventions:  Drug: Bintrafusp Alfa;  Drug: Pimasertib;  Other: Quality-of-Life Assessment
Sponsor:  M.D. Anderson Cancer Center
**RECRUITING NOW**
Interventions:  Drug: Bintrafusp Alfa;  Drug: Pimasertib;  Other: Quality-of-Life Assessment
Sponsor:  M.D. Anderson Cancer Center
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
